H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Census population 112,644. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lansing clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lansing storefront.
Non-Surgical Regenerative Therapy Options in Lansing, MI for clinics & physicians. Give patients non-surgi… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Michigan chart is a denial pattern. You are J8. CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Use Michigan Department of Health & Human Services for community education; use the IFU for the product in the fridge. non surgical regenerative therapy is the SKU conversation, not a patient appointment book.
National Non-Surgical Regenerative Therapy Options notes (how the product actually works)Three grains, kept separate on purpose. City: Census 112,644 and CDC PLACES crude rates. State: Michigan Department of Health & Human Services, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and WPS Government Health Administrators LCDs. CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 12.4% of adults in Lansing have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Adult arthritis here is 26.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Lansing.
CDC PLACES (2023, crude prevalence) estimates 12.4% of adults — 0.4 points above the U.S. 12% figure. Obesity is 39.9%; arthritis is 26.9%. That is place-level BRFSS modeling, not a clinic census and not a Lansing trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Michigan compliance risk.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Michigan is in CMS MAC J8, administered by WPS Government Health Administrators. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Bring specialty, monthly joint / regenerative volume, and whether you bill J8 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.4% diabetes and 26.9% arthritis for Lansing — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Lansing, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lansing is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Lansing — 0.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Lansing. Useful for joint-program math; still needs a diagnosis and privileging.
No Lansing storefront. Joe Bradley is an active practice owner. non surgical regenerative therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.